Can a string replace endoscopies? | FDA approves Geneoscopy test | Dangers of declining GI reimbursements

FDA Approves ColoSense? – Geneoscopy’s Noninvasive Multi-target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test (Business Wire)

In the CRC-PREVENT trial, ColoSense? demonstrated a high sensitivity of 93% for detecting CRC and identified 100% of stage I colorectal cancers.

The dangers of declining gastroenterology reimbursements (Becker’s GI & Endoscopy)

Colonoscopy demand is continuing to grow as gastroenterologists and GI practices face ever-declining reimbursements.

Test-at-home kit for cancer patients approved for use (BBC)

A new device called the Liberty, which allows cancer patients to conduct blood tests at home, has received regulatory approval.

Exact Sciences Announces First-Quarter 2024 Results (Business Wire)

Exact Sciences delivered more than a million Cologuard? and Oncotype DX? test results to patients. They also published Cologuard Plus? test results from pivotal BLUE-C study in The New England Journal of Medicine.

Are new colorectal cancer screening options a match for 'the gold standard'? (Healio ) ?

New blood and stool tests may improve uptake of colorectal cancer screening because of the discomfort around colonoscopies.

Artificial Intelligence in GI and Hepatology (MDedge)

Dr. Thomas R. McCarty and Dr. Nabil M. Mansour highlight the profound impact of AI, particularly in gastrointestinal endoscopy.

Insurance Hurdles Compound Difficulties for IBD Patient Care (GI & Endoscopy News)

Insurer-mandated barriers, such as prior authorizations and medication denials, negatively impact patients with inflammatory bowel disease (IBD).

Docs Vent As Feds Investigate Private Equity, Consolidation in Medicine (Medscape)

While some praise the efficiency brought by PE, others criticize it for prioritizing profits over patient care and for contributing to physician burnout.

‘A Simple Idea That Could Make a Substantial Impact’: Can a String Replace Endoscopies for Esophageal Cancer, Other Disorders? (University of Colorado)

The EnteroTracker, developed by Dr. Robin Shandas and his team offers a novel and less invasive method for diagnosing esophageal cancer and other upper gastrointestinal disorders.

Denver Digestive Health Specialists Expands Into Arvada (GlobeNewswire)

With state-of-the-art facilities and the introduction of new treatments like Vedolizumab, the clinic is poised to significantly enhance the quality of care for patients with digestive health issues.

Endoscopic procedure burns stomach lining to reduce 'hunger hormone' and lead to weight loss (Medical Xpress)

A novel endoscopic procedure that ablates the stomach lining to reduce ghrelin production was detailed in a first-in-human trial at DDW 2024.

A Sneak Peek at Digestive Disease Week 2024 (GI Insights)

The sessions will cover innovative research areas like the brain-gut axis, stem cell therapies, and the emerging significance of microbiome in precision nutrition.

5 notes on Ozempic for gastroenterologists (Becker’s GI & Endoscopy)

Usage of weight loss medications including Glucagon-like peptide-1 receptor agonists such as Ozempic has skyrocketed in the U.S. in the last year, affecting numerous medical specialties.

7 Spatial Computing Startups That Could Change Healthcare Forever (Startup Info)

The article discusses the transformative role of spatial computing in healthcare, driven by the advancements in AR, VR, and XR technologies.

For weekly gastroenterology business/tech updates directly in your inbox, subscribe to the Scope Forward newsletter.

Get the book: Scope Forward - The Future of Gastroenterology Is Now In Your Hands.